-
PDF
- Split View
-
Views
-
Cite
Cite
Joseph Irudayaraj Arutchelvi, Sumit Bhaduri, Parasu Veera Uppara, Mukesh Doble, Mannosylerythritol lipids: a review, Journal of Industrial Microbiology and Biotechnology, Volume 35, Issue 12, 1 December 2008, Pages 1559–1570, https://doi.org/10.1007/s10295-008-0460-4
- Share Icon Share
Abstract
Mannosylerythritol lipids (MELs) are surface active compounds that belong to the glycolipid class of biosurfactants (BSs). MELs are produced by Pseudozyma sp. as a major component while Ustilago sp. produces them as a minor component. Although MELs have been known for over five decades, they recently regained attention due to their environmental compatibility, mild production conditions, structural diversity, self-assembling properties and versatile biochemical functions. In this review, the MEL producing microorganisms, the production conditions, their applications, their diverse structures and self-assembling properties are discussed. The biosynthetic pathways and the regulatory mechanisms involved in the production of MEL are also explained here.
Introduction
Biosurfactants (BSs) or microbial surface active compounds are of recent interest due to their unique properties including structural diversity, higher biodegradability, lower toxicity, higher foaming ability, higher selectivity and specific activity at extreme conditions (pH, temperature and ionic strength) and mild production conditions when compared to the chemical surfactants. BSs are amphiphilic molecules with polar and non-polar domains [6, 13, 42, 53, 59]. There are five main classes of BSs, namely lipopeptides; glycolipids; fatty acids including neutral lipids and phospholipids; polymeric and particulate [6, 13, 53, 59]. Among these, the first two classes show wide range of applications in food, cosmetics, and pharmaceutical industries [3, 6, 57, 61, 62]. They are used in removing soil contaminants including heavy metals, oils and other toxic pollutants [13, 52, 53, 61]. Some of the BSs are potential antimicrobial agents and are suitable alternatives to synthetic antibiotics [3, 38, 57, 62].
Except for a few, the physiological roles of BSs in general are not yet completely characterized. BSs are essential for the motility (swarming and gliding) of the microorganisms. For example, surfactin production and flagellar biosynthesis are crucial for swarming motility in B. subtilis [13, 30]. Similarly, Serratia marcescens depends on serrawettin for surface locomotion and access to water repelling surfaces [13, 47]. 3-(3-Hydroxyalkanoyloxy) alkanoic acid (HAA), the intermediate in the rhamnolipid biosynthesis pathway, plays an essential role in swarming motility [7, 13]. BSs regulate the attachment and detachment of the microorganisms to or from solid substrates [13, 53, 58]. Rhamnolipids are essential to maintain the architecture of the biofilm [4, 13] and are considered as one of the virulence factors in Pseudomonas sp. [4, 13, 58]. Rhamnolipids, mannosylerythritol lipid and surfactin are a few examples of BSs showing antimicrobial and antibiotic properties. Thus they confer a competitive advantage to the organism during colonization and cell–cell competition [13, 58]. BSs enhance the accessibility of hydrocarbon substrates by forming small emulsion droplets and increase the surface area of the insoluble substrates [13, 53, 58]. BSs form complex (chelate) with heavy metals including Cd2+, Pb2+, Zn2+ and Hg2+ and hence reduce their toxicity [13, 52, 58]. They act as carbon and energy storage molecules and remain as a protective layer for the microorganisms against the environment with high ionic strength [41, 42, 58]. BSs may be the byproducts released in response to the environmental changes and may have a role in DNA transfer in natural environment, since they can enhance gene uptake via transfection [13, 23, 24, 58, 61].
![Structure of MEL [43] (MEL-A: R1 = R2 = Ac; MEL-B: R1 = Ac, R2 = H; MEL-C: R1 = H, R2 = Ac: n = 6–10)](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jimb/35/12/10.1007_s10295-008-0460-4/2/m_10295_2008_460_fig1_html.gif?Expires=1747993863&Signature=Q2TCbFMxT6dg2SkQkOBRVx90CJcuY1ljuc9iXA40HD17cm-GSVxG2aFBTYu5UDX9q~0QxQb8Ls~na6AkGpYqqEpyvLCliXlsEbbt3324XXNRuOsnMSkMDiKkLD899tCUeFmd33hTnuA6brWWgAMoAcZXEqX9dtmkAr4bhHFtK~wd2mq5Nw-jEqrjiVXFXH3T9gzwtvZyIdSonzoIAAWXWBfT5aePwvDqSLfEj~Vup2oltzEfqFSnEW~nSZ6adAW1wqcWDeg3FvJOecsY4isnQy9lpeQ-anWAlx~bOitb1JpUp14MxLrC5Uo8skibBFv0P79dqGnVDJT3Kjg-JMRV6g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Structure of MEL [43] (MEL-A: R1 = R2 = Ac; MEL-B: R1 = Ac, R2 = H; MEL-C: R1 = H, R2 = Ac: n = 6–10)
MEL: why?
The increasing interest in MELs could be attributed to their pharmaceutical applications [60, 73] and versatile biochemical functions including antitumor and differentiation inducing activities against human leukemia cells, rat peochromocytoma cells and mouse melanoma cells [25–27, 68, 71–73]. They can be used in the treatment of schizophrenia or diseases caused by dopamine metabolic dysfunction [67, 72] and microbial infections [37]. MELs are used in the purification of lectins (Immunoglobulin G) [9, 15, 16, 21, 39] and in the preparation of ice-slurry as an anti-agglomeration agent [41, 42]. Self-assembling properties [17–20, 39, 43, 70] of MELs are of recent interest because this behavior could be leveraged in gene transfection and drug delivery [23, 24, 42, 43, 65, 66]. The increasing number of novel MEL producers, their proven structural diversity, their self-assembling properties and myriad applications are discussed in this review.
Structural diversity of MEL and its microbial sources
MELs are secreted by several microorganisms and they are first noted as oily compounds in the cultured suspension of Ustilago maydis PRL-627 by Haskins et al. [14]. This microorganism was shown to produce MEL along with CL when glucose was used as the carbon source [2, 8, 14]. Bhatttacharjee et al. [1] characterized MEL as a glycolipid, especially as a mixture of partially acylated derivative of 4-O-β-d-mannopyranosyl-d-erythritol, containing C2:0, C12:0, C14:0, C14:1, C16:0, C16:1, C18:0 and C18:1 fatty acids as the hydrophobic groups. Schizonella melanogramma was the second microorganism identified as a MEL producer (schizonellin), but not in association with CL [5]. Table 1 summarizes the structural variants of the MELs and the corresponding microbial sources. These variants arise due to the following reasons:
Structural variants of MEL and their corresponding microbial sources
Microorganism . | Sugar . | Fatty acid profile . | Type of MEL (major component) . | References . |
---|---|---|---|---|
Ustilago nuda PRL-627 | 4-O-β-d-mannopyranosyl-d-erythritol | C2:0, C12:0, C14:0, C14:1, C16:0, C16:1, C18:0, and C18:1 | NA | [1] |
Candida (Pseudozyma) sp. B7 | 4-O-β-d-mannopyranosyl-d-erythritol | C7–C14 | MEL-B7 | [29] |
Pseudozyma antarctica T-34 | 4-O-β-d-mannopyranosyl-erythritol | C8:0 (27.26%), C10:0 (21.28%), C10:1 (27.22%) | MEL-A and MEL-B (it produce all four types) | [34, 40] |
Ustilago maydis DSM 4500 and ATCC 1482 | 4-O-β-d-mannopyranosyl-d-erythritol | C14:1 (43%), C6:0 (20%) and C16:1 (12%) | MEL-A | [63] |
Schizonella melanogramma | 4-O-β-d-mannopyranosyl-d-erythritol | C14:0, C16:1, C16:0, C18:0, C18:1 | Schizonellin A and schizonellin B (similar to MEL-A and -B) | [5] |
Kurtzmanomyces sp. I-11 | 6-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8:0 (36.4%), C12:0 (11.9%), C14:2 (25.9%) | MEL-I-11 | [28] |
Candida sp. SY16 | 6-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C6:0, C12:0, C14:0, and C14:1 | MEL-A | [31] |
Pseudozyma aphidis DSM 70725 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C10:0, C10:1, and C8:0 | MEL-A | [54] |
Pseudozyma rugulosa NBRC 10877 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8:0 (28.09%), C10:0 (21.68%), C10:1 (22.94%) | MEL-A | [48] |
Pseudozyma hubeiensis KM-59 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C6, C12 and C16 | MEL-C (65%) | [45, 46] |
Pseudozyma shaxiensis | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C16:0, C16:1, C16:2, and C14:1 | MEL-C | [10] |
P. tsukubaensis JCM 10324T | 1-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8, C12, C14 | MEL-B with new diastereomer of sugar | [12, 49] |
P. fusiformata | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C6 and C8 | MEL-A | [49] |
Pseudozyma graminicola CBS 10092 | 4-O-β-d-mannopyranosyl-(1→ 4)-D-meso-erythritol | C6:0, C8:0, C12:0, C12:1, C14:0, and C14:1 | MEL-C (85%) | [50] |
P. antarctica and P. parantarctica | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8:0, C10:0, C12:0, C14:0, C14:1 | Monoacylated MEL | [11] |
P. antarctica and P. rugulosa | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C18:1, C18:0, C10:0, C10:1, C16:0, and C8:0 | Triacylated MEL | [44] |
P. siamensis CBS 9960 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C14:2, C16:0, C16:1, C16:2 (C2 or C4) at the C-2′ position and (C16) at the C-3′ position of the mannose moiety | MEL-C mixture of monoacetylation and diacetylation | [57] |
Microorganism . | Sugar . | Fatty acid profile . | Type of MEL (major component) . | References . |
---|---|---|---|---|
Ustilago nuda PRL-627 | 4-O-β-d-mannopyranosyl-d-erythritol | C2:0, C12:0, C14:0, C14:1, C16:0, C16:1, C18:0, and C18:1 | NA | [1] |
Candida (Pseudozyma) sp. B7 | 4-O-β-d-mannopyranosyl-d-erythritol | C7–C14 | MEL-B7 | [29] |
Pseudozyma antarctica T-34 | 4-O-β-d-mannopyranosyl-erythritol | C8:0 (27.26%), C10:0 (21.28%), C10:1 (27.22%) | MEL-A and MEL-B (it produce all four types) | [34, 40] |
Ustilago maydis DSM 4500 and ATCC 1482 | 4-O-β-d-mannopyranosyl-d-erythritol | C14:1 (43%), C6:0 (20%) and C16:1 (12%) | MEL-A | [63] |
Schizonella melanogramma | 4-O-β-d-mannopyranosyl-d-erythritol | C14:0, C16:1, C16:0, C18:0, C18:1 | Schizonellin A and schizonellin B (similar to MEL-A and -B) | [5] |
Kurtzmanomyces sp. I-11 | 6-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8:0 (36.4%), C12:0 (11.9%), C14:2 (25.9%) | MEL-I-11 | [28] |
Candida sp. SY16 | 6-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C6:0, C12:0, C14:0, and C14:1 | MEL-A | [31] |
Pseudozyma aphidis DSM 70725 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C10:0, C10:1, and C8:0 | MEL-A | [54] |
Pseudozyma rugulosa NBRC 10877 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8:0 (28.09%), C10:0 (21.68%), C10:1 (22.94%) | MEL-A | [48] |
Pseudozyma hubeiensis KM-59 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C6, C12 and C16 | MEL-C (65%) | [45, 46] |
Pseudozyma shaxiensis | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C16:0, C16:1, C16:2, and C14:1 | MEL-C | [10] |
P. tsukubaensis JCM 10324T | 1-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8, C12, C14 | MEL-B with new diastereomer of sugar | [12, 49] |
P. fusiformata | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C6 and C8 | MEL-A | [49] |
Pseudozyma graminicola CBS 10092 | 4-O-β-d-mannopyranosyl-(1→ 4)-D-meso-erythritol | C6:0, C8:0, C12:0, C12:1, C14:0, and C14:1 | MEL-C (85%) | [50] |
P. antarctica and P. parantarctica | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8:0, C10:0, C12:0, C14:0, C14:1 | Monoacylated MEL | [11] |
P. antarctica and P. rugulosa | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C18:1, C18:0, C10:0, C10:1, C16:0, and C8:0 | Triacylated MEL | [44] |
P. siamensis CBS 9960 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C14:2, C16:0, C16:1, C16:2 (C2 or C4) at the C-2′ position and (C16) at the C-3′ position of the mannose moiety | MEL-C mixture of monoacetylation and diacetylation | [57] |
NA not available
Structural variants of MEL and their corresponding microbial sources
Microorganism . | Sugar . | Fatty acid profile . | Type of MEL (major component) . | References . |
---|---|---|---|---|
Ustilago nuda PRL-627 | 4-O-β-d-mannopyranosyl-d-erythritol | C2:0, C12:0, C14:0, C14:1, C16:0, C16:1, C18:0, and C18:1 | NA | [1] |
Candida (Pseudozyma) sp. B7 | 4-O-β-d-mannopyranosyl-d-erythritol | C7–C14 | MEL-B7 | [29] |
Pseudozyma antarctica T-34 | 4-O-β-d-mannopyranosyl-erythritol | C8:0 (27.26%), C10:0 (21.28%), C10:1 (27.22%) | MEL-A and MEL-B (it produce all four types) | [34, 40] |
Ustilago maydis DSM 4500 and ATCC 1482 | 4-O-β-d-mannopyranosyl-d-erythritol | C14:1 (43%), C6:0 (20%) and C16:1 (12%) | MEL-A | [63] |
Schizonella melanogramma | 4-O-β-d-mannopyranosyl-d-erythritol | C14:0, C16:1, C16:0, C18:0, C18:1 | Schizonellin A and schizonellin B (similar to MEL-A and -B) | [5] |
Kurtzmanomyces sp. I-11 | 6-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8:0 (36.4%), C12:0 (11.9%), C14:2 (25.9%) | MEL-I-11 | [28] |
Candida sp. SY16 | 6-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C6:0, C12:0, C14:0, and C14:1 | MEL-A | [31] |
Pseudozyma aphidis DSM 70725 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C10:0, C10:1, and C8:0 | MEL-A | [54] |
Pseudozyma rugulosa NBRC 10877 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8:0 (28.09%), C10:0 (21.68%), C10:1 (22.94%) | MEL-A | [48] |
Pseudozyma hubeiensis KM-59 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C6, C12 and C16 | MEL-C (65%) | [45, 46] |
Pseudozyma shaxiensis | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C16:0, C16:1, C16:2, and C14:1 | MEL-C | [10] |
P. tsukubaensis JCM 10324T | 1-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8, C12, C14 | MEL-B with new diastereomer of sugar | [12, 49] |
P. fusiformata | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C6 and C8 | MEL-A | [49] |
Pseudozyma graminicola CBS 10092 | 4-O-β-d-mannopyranosyl-(1→ 4)-D-meso-erythritol | C6:0, C8:0, C12:0, C12:1, C14:0, and C14:1 | MEL-C (85%) | [50] |
P. antarctica and P. parantarctica | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8:0, C10:0, C12:0, C14:0, C14:1 | Monoacylated MEL | [11] |
P. antarctica and P. rugulosa | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C18:1, C18:0, C10:0, C10:1, C16:0, and C8:0 | Triacylated MEL | [44] |
P. siamensis CBS 9960 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C14:2, C16:0, C16:1, C16:2 (C2 or C4) at the C-2′ position and (C16) at the C-3′ position of the mannose moiety | MEL-C mixture of monoacetylation and diacetylation | [57] |
Microorganism . | Sugar . | Fatty acid profile . | Type of MEL (major component) . | References . |
---|---|---|---|---|
Ustilago nuda PRL-627 | 4-O-β-d-mannopyranosyl-d-erythritol | C2:0, C12:0, C14:0, C14:1, C16:0, C16:1, C18:0, and C18:1 | NA | [1] |
Candida (Pseudozyma) sp. B7 | 4-O-β-d-mannopyranosyl-d-erythritol | C7–C14 | MEL-B7 | [29] |
Pseudozyma antarctica T-34 | 4-O-β-d-mannopyranosyl-erythritol | C8:0 (27.26%), C10:0 (21.28%), C10:1 (27.22%) | MEL-A and MEL-B (it produce all four types) | [34, 40] |
Ustilago maydis DSM 4500 and ATCC 1482 | 4-O-β-d-mannopyranosyl-d-erythritol | C14:1 (43%), C6:0 (20%) and C16:1 (12%) | MEL-A | [63] |
Schizonella melanogramma | 4-O-β-d-mannopyranosyl-d-erythritol | C14:0, C16:1, C16:0, C18:0, C18:1 | Schizonellin A and schizonellin B (similar to MEL-A and -B) | [5] |
Kurtzmanomyces sp. I-11 | 6-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8:0 (36.4%), C12:0 (11.9%), C14:2 (25.9%) | MEL-I-11 | [28] |
Candida sp. SY16 | 6-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C6:0, C12:0, C14:0, and C14:1 | MEL-A | [31] |
Pseudozyma aphidis DSM 70725 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C10:0, C10:1, and C8:0 | MEL-A | [54] |
Pseudozyma rugulosa NBRC 10877 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8:0 (28.09%), C10:0 (21.68%), C10:1 (22.94%) | MEL-A | [48] |
Pseudozyma hubeiensis KM-59 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C6, C12 and C16 | MEL-C (65%) | [45, 46] |
Pseudozyma shaxiensis | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C16:0, C16:1, C16:2, and C14:1 | MEL-C | [10] |
P. tsukubaensis JCM 10324T | 1-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8, C12, C14 | MEL-B with new diastereomer of sugar | [12, 49] |
P. fusiformata | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C6 and C8 | MEL-A | [49] |
Pseudozyma graminicola CBS 10092 | 4-O-β-d-mannopyranosyl-(1→ 4)-D-meso-erythritol | C6:0, C8:0, C12:0, C12:1, C14:0, and C14:1 | MEL-C (85%) | [50] |
P. antarctica and P. parantarctica | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C8:0, C10:0, C12:0, C14:0, C14:1 | Monoacylated MEL | [11] |
P. antarctica and P. rugulosa | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C18:1, C18:0, C10:0, C10:1, C16:0, and C8:0 | Triacylated MEL | [44] |
P. siamensis CBS 9960 | 4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritol | C14:2, C16:0, C16:1, C16:2 (C2 or C4) at the C-2′ position and (C16) at the C-3′ position of the mannose moiety | MEL-C mixture of monoacetylation and diacetylation | [57] |
NA not available
Number and position of the acetyl group on mannose or erythritol or both.
Number of acylation in mannose.
Fatty acid chain length and their saturation.
The acyl residues in MEL ranged from C7 to C14 and their proportions varied depending upon the carbon source used. For example, Candida sp. B-7 (currently known as Pseudozyma antarctica) produced 4-O-(2′, 6′-di-O-acyl-β-d-mannopyranosyl)-d-erythritol with high yield (25–36 g/L), when it was grown on n-alkane or triglycerides at 30 °C for 7 days but not with carbohydrate as the carbon source [29]. Based on the degree of acetylation at C4 and C6 position, and their order of appearance on the thin layer chromatography (TLC), the MELs (from P. aphidis) are classified as MEL-A, -B, -C and -D. MEL-A representing the diacetylated compound while MEL-B and MEL-C are monoacetylated at C6 and C4, respectively. The completely deacetylated structure is known as MEL-D [54]. Mixtures of these four MELs but predominantly MEL-A and MEL-B were isolated from Candida antarctica strain T34 [33]. Excellent surface active and antimicrobial properties of MELs isolated from T-34 were reported by Kitamoto et al. [37].
Kurtzmanomyces sp. I-11 produces a novel MEL composed of a sugar moiety, 6-O-β-d-mannopyranosyl-(1 → 4)-O-meso-erythritol and a mixture of fatty acids [C8:0 (36.4%), C12:0 (11.9%) and C14:2 (25.9)] [28] as the lipophylic group. Candida antarctica KCTC 7804 which was isolated from an oil contaminated site, produced a MEL containing 6-O-acetyl-2, 3-di-O-alkanoyl-β-d-mannopyranosyl-(1 → 4)-O-meso-erythritol. The lipophilic group of this MEL is a mixture of hexanoic, dodecanoic, tetradecanoic and tetradecenoic fatty acids. The acetyl group is linked at the C-6 position of the d-mannose [31]. Pseudozyma rugulosa NBRC 10877 is reported to produce from soybean oil a mixture of MEL-A (68%), MEL-B (12%) and MEL-C (20%) consisting of C8 and C10 fatty acids as the hydrophobic moiety [48]. P. fusiformata, P. parantarctica and P. tsukubaensis are identified as MEL producers and of these three strains; P. parantarctica produces the highest quantity of MEL (30 g/L). Interestingly, P. parantarctica and P. fusiformata produce mainly MEL-A, whereas P. tsukubaensis produces MEL-B. The strains of Pseudozyma are classified into four groups such as, the first group produces largely MEL; the second produces both MEL and other biosurfactants; the third produces mainly MEL-B; and the fourth produces non-MEL BS [49]. Hence the production of MEL can be used as an important taxonomic index to identify Pseudozyma yeasts [10, 49–51].
![Structure of 4-O-[(2′,4′-di-O-acetyl-3′-O-alka(e)noyl)-β-d-mannopyranosyl]-d-erythritol; R2 = Ac; n = 12–16](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jimb/35/12/10.1007_s10295-008-0460-4/2/m_10295_2008_460_fig2_html.gif?Expires=1747993863&Signature=m~GrKJPVMc3SSEUIzTTUYtPcNpN-Lks~4okZbF1oNVQC-sO5nhZp~7s4WJYJjw8wEOrkkGbUHRPURl~LNE6-YGVqFokdm8ucb7GaDGpHI5jmT4Bysw7wn6kEq6SaI-yb5xrE8KbG96Mvme6-DmUC7KjPUihhWRpaE9Vy59j5nQCvQStOjnzty4nzDMNb6oBbDtxezHFzgZZIOrqKWwLMWd~3tEmdQM1pI2Xz4w-EtJcr69RyonWtxuL1Gg556FxHjK7Pxvt6e2~hNfvX1qA53DYj-ICFn88jQGBNPE76Pkydg6c18wuWkPYwCJe~6UGnQvmsUaKiYHh1iUIcxfnG8w__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Structure of 4-O-[(2′,4′-di-O-acetyl-3′-O-alka(e)noyl)-β-d-mannopyranosyl]-d-erythritol; R2 = Ac; n = 12–16
![Structure of 4-O-[(4′-O-acetyl-3′-O-alka(e)noyl-2′-O-butanoyl)-β-d-mannopyranosyl]-d-erythritol; R2 = Ac; n = 12–16](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jimb/35/12/10.1007_s10295-008-0460-4/2/m_10295_2008_460_fig3_html.gif?Expires=1747993863&Signature=c9kyCFKSL0ldENs~WdGLY12jAaLokMoQdfJYkcloiiRjFGPTvHpAa6N6BEolpY4YtR6aOf~5UEW1zKTgV2l0Z96bAhoOQ9g99KYpZOJryC5dSOYKWcbG3ddVugHopcv6nAkyNxQdb6UxPuAP97zLGICuaGFYDXi0f9bq9Hof72Z-tDpC3VE~UQYIjMnniw-ZI75hXr2UlRY9GB1rxsecSzJ-GYmF9iaUJiwolYpykIrAMXHXSGyENEi82oVcCghCDPD9zvfhqf3egB9MV4HOpxVTZsb17H2-b0hfgseSSi6pLd6NMySGfFmvZMWHQ2-wNh0BlssTiHEEesRBPC7HWQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Structure of 4-O-[(4′-O-acetyl-3′-O-alka(e)noyl-2′-O-butanoyl)-β-d-mannopyranosyl]-d-erythritol; R2 = Ac; n = 12–16



Structural variants of MEL and their surface activities
Type of MEL . | Critical micelle concentration (M) . | Surface tension (mN/m) . | Interfacial tension (mN/m) . | References . |
---|---|---|---|---|
MEL-A | 2.7 × 10−6 | 28.4 | 2.1 | [37] |
MEL-B | 4.5 × 10−6 | 28.2 | 2.4 | [37] |
MEL-C (from P. hubeiensis KM-59) | 6.0 × 10−6 | 25.1 | – | [46] |
MEL-C (from P. graminicola CBS 10092) | 4.0 × 10−6 | 24.2 | – | [50] |
MEL-C (from P. siamensis CBS 9960) | 4.5 × 10−6 | 30.7 | – | [57] |
Monoacylated MEL | 3.6 × 10−4 | 33.8 | – | [11] |
Type of MEL . | Critical micelle concentration (M) . | Surface tension (mN/m) . | Interfacial tension (mN/m) . | References . |
---|---|---|---|---|
MEL-A | 2.7 × 10−6 | 28.4 | 2.1 | [37] |
MEL-B | 4.5 × 10−6 | 28.2 | 2.4 | [37] |
MEL-C (from P. hubeiensis KM-59) | 6.0 × 10−6 | 25.1 | – | [46] |
MEL-C (from P. graminicola CBS 10092) | 4.0 × 10−6 | 24.2 | – | [50] |
MEL-C (from P. siamensis CBS 9960) | 4.5 × 10−6 | 30.7 | – | [57] |
Monoacylated MEL | 3.6 × 10−4 | 33.8 | – | [11] |
Structural variants of MEL and their surface activities
Type of MEL . | Critical micelle concentration (M) . | Surface tension (mN/m) . | Interfacial tension (mN/m) . | References . |
---|---|---|---|---|
MEL-A | 2.7 × 10−6 | 28.4 | 2.1 | [37] |
MEL-B | 4.5 × 10−6 | 28.2 | 2.4 | [37] |
MEL-C (from P. hubeiensis KM-59) | 6.0 × 10−6 | 25.1 | – | [46] |
MEL-C (from P. graminicola CBS 10092) | 4.0 × 10−6 | 24.2 | – | [50] |
MEL-C (from P. siamensis CBS 9960) | 4.5 × 10−6 | 30.7 | – | [57] |
Monoacylated MEL | 3.6 × 10−4 | 33.8 | – | [11] |
Type of MEL . | Critical micelle concentration (M) . | Surface tension (mN/m) . | Interfacial tension (mN/m) . | References . |
---|---|---|---|---|
MEL-A | 2.7 × 10−6 | 28.4 | 2.1 | [37] |
MEL-B | 4.5 × 10−6 | 28.2 | 2.4 | [37] |
MEL-C (from P. hubeiensis KM-59) | 6.0 × 10−6 | 25.1 | – | [46] |
MEL-C (from P. graminicola CBS 10092) | 4.0 × 10−6 | 24.2 | – | [50] |
MEL-C (from P. siamensis CBS 9960) | 4.5 × 10−6 | 30.7 | – | [57] |
Monoacylated MEL | 3.6 × 10−4 | 33.8 | – | [11] |
Microbial production condition
The production of MEL in shake flask is reported while very few attempts have been made to produce it in a fermentor. Seed cultures are prepared by inoculating cells grown on slants into test tubes containing a growth medium [4% glucose, 0.3% NaNO3, 0.03% MgSO4, 0.03% KH2PO4, 0.1% yeast extract (pH 6.0)] at 25 °C on a reciprocal shaker (150 rpm) for 2 days [10, 33, 34, 56]. Exactly 1 mL of the seed culture is transferred to a 300 mL Erlenmeyer flask containing 30 mL of the basal medium [4% olive oil, 0.3% NaNO3, 0.03% MgSO4, 0.03% KH2PO4, 0.1% yeast extract (pH 6.0)], which is then incubated on a rotary shaker (220 rpm) at 28 °C for 7 days.
Isolation of glycolipid is carried out by solvent extraction. Equal volumes of ethyl acetate and culture medium are mixed together and are allowed to separate in a separating funnel. Solvent layer is collected and evaporated. This fraction is analyzed using TLC on silica plates (Silica gel 60F; Wako) with a solvent system consisting of chloroform/methanol/7 N ammonia solution (65:15:2, by vol). The compounds on the plates are located by charring them at 110 °C for 5 min after spraying a mixture of anthrone and sulfuric acid [10, 34, 56]. The concentrated glycolipids are dissolved in chloroform and then purified by silica gel (Wako-gel C-200) column chromatography using a gradient elution technique with chloroform–acetone (10:0–0:10, vol/vol) solvent mixtures [10, 56]. Table 3 summarizes the production conditions and the corresponding yield in the preparation of MEL by Pseudozyma sp.
Effect of the culture conditions and carbon source on the production and composition of MEL by Pseudozyma sp.
Type of MEL . | Yield (g/L) . | Conditions . | References . |
---|---|---|---|
MEL-B7 | 30 | n-Alkane or vegetable oils; batch culture | [29] |
Mixture of MEL-A, -B and -C | 47 | Soybean oil and resting cells; batch culture | [35] |
Mixture of MEL-A, -B, -C and D | 40 | Vegetable oils, yeast extract and batch culture | [34] |
30 | Sunflower oil; batch culture | [34] | |
Mixture of MEL-A, -B and -C | 140 | Octadecane; batch culture | [40, 42] |
Mixture of MEL-A, -B, and -C | 165 | Soybean oil and fed batch reactor | [55] |
Mixture of MEL homologs | 95 | Glucose:soybean oil (1:1) and intermittent addition of soybean—fed batch culture | [32] |
MEL-B | 25 | Soybean oil batch culture | [12, 45] |
MEL-C | 15 | Soybean oil batch culture | [45] |
MEL-C | 76.3 | Soybean oil and fed batch reactor | [46] |
Type of MEL . | Yield (g/L) . | Conditions . | References . |
---|---|---|---|
MEL-B7 | 30 | n-Alkane or vegetable oils; batch culture | [29] |
Mixture of MEL-A, -B and -C | 47 | Soybean oil and resting cells; batch culture | [35] |
Mixture of MEL-A, -B, -C and D | 40 | Vegetable oils, yeast extract and batch culture | [34] |
30 | Sunflower oil; batch culture | [34] | |
Mixture of MEL-A, -B and -C | 140 | Octadecane; batch culture | [40, 42] |
Mixture of MEL-A, -B, and -C | 165 | Soybean oil and fed batch reactor | [55] |
Mixture of MEL homologs | 95 | Glucose:soybean oil (1:1) and intermittent addition of soybean—fed batch culture | [32] |
MEL-B | 25 | Soybean oil batch culture | [12, 45] |
MEL-C | 15 | Soybean oil batch culture | [45] |
MEL-C | 76.3 | Soybean oil and fed batch reactor | [46] |
Effect of the culture conditions and carbon source on the production and composition of MEL by Pseudozyma sp.
Type of MEL . | Yield (g/L) . | Conditions . | References . |
---|---|---|---|
MEL-B7 | 30 | n-Alkane or vegetable oils; batch culture | [29] |
Mixture of MEL-A, -B and -C | 47 | Soybean oil and resting cells; batch culture | [35] |
Mixture of MEL-A, -B, -C and D | 40 | Vegetable oils, yeast extract and batch culture | [34] |
30 | Sunflower oil; batch culture | [34] | |
Mixture of MEL-A, -B and -C | 140 | Octadecane; batch culture | [40, 42] |
Mixture of MEL-A, -B, and -C | 165 | Soybean oil and fed batch reactor | [55] |
Mixture of MEL homologs | 95 | Glucose:soybean oil (1:1) and intermittent addition of soybean—fed batch culture | [32] |
MEL-B | 25 | Soybean oil batch culture | [12, 45] |
MEL-C | 15 | Soybean oil batch culture | [45] |
MEL-C | 76.3 | Soybean oil and fed batch reactor | [46] |
Type of MEL . | Yield (g/L) . | Conditions . | References . |
---|---|---|---|
MEL-B7 | 30 | n-Alkane or vegetable oils; batch culture | [29] |
Mixture of MEL-A, -B and -C | 47 | Soybean oil and resting cells; batch culture | [35] |
Mixture of MEL-A, -B, -C and D | 40 | Vegetable oils, yeast extract and batch culture | [34] |
30 | Sunflower oil; batch culture | [34] | |
Mixture of MEL-A, -B and -C | 140 | Octadecane; batch culture | [40, 42] |
Mixture of MEL-A, -B, and -C | 165 | Soybean oil and fed batch reactor | [55] |
Mixture of MEL homologs | 95 | Glucose:soybean oil (1:1) and intermittent addition of soybean—fed batch culture | [32] |
MEL-B | 25 | Soybean oil batch culture | [12, 45] |
MEL-C | 15 | Soybean oil batch culture | [45] |
MEL-C | 76.3 | Soybean oil and fed batch reactor | [46] |
Rau et al. [56] reported the production of MEL in a bioreactor and the various downstream processing strategies for its recovery and purification. Solvent extraction, adsorption on different types of Amberlite XAD followed by solvent extraction and heating the culture suspension to 110 °C for 10 min were the three downstream methods reported. The last method gave the highest yield of 93 wt% with a purity of 87 wt%, whereas the solvent extraction method gave only 79 wt% yield with 100 wt% purity [56].
Biosynthetic pathway of MEL
Kitamoto et al. [37, 43] attempted to relate the substrate and the corresponding product structures. When fatty alcohols or acids of chain length of Cn were used, the products formed were with the chain length of Cn−2, Cn−4, Cn−6, etc. [36, 42]. The authors concluded that the products were the β-oxidation intermediates of the substrates supplied.
2-Bromooctanoic acid [38, 42] (strong inhibitor of the fatty acid β-oxidation) inhibited the production of MEL and the degree of inhibition increased with the increase in the chain length of the substrate supplied. The cerulenin (strong inhibitor to de novo fatty acid synthesis) did not affect the fatty acid composition of MEL. In general, once the fatty acid entered the β-oxidation pathway, it was completely oxidized to an acetyl CoA and the intermediates did not leak out from this cycle [42, 64]. Two types of β-oxidation cycles are present in mammals, namely peroxisomal partial β-oxidation and mitochondrial complete β-oxidation. The former is responsible for the shortening of long and very long chain fatty acids which are then converted into acetyl CoA in the latter cycle [42, 69]. The biosynthetic “chain shortening” pathway of MEL is different from the three generally known pathways in microorganisms, namely, de novo synthesis, chain elongation and intact incorporation [42].
Self-assembling properties of MEL
Self-assembly (SA) can be defined as the spontaneous and reversible organization of molecular units into ordered structures by non-covalent interactions without the application of external force or stimulus. Any amphiphilic molecule possesses this ability. For example, ionic and nonionic surfactants at high concentrations can self-assemble into three-dimensional ordered lyotropic liquid crystals including sponge, cubic, lamella, and hexagonal phases. Natural sugar-based surfactants exhibit the above-mentioned behavior and in addition they posses several advantages over the synthetic ones including high biodegradability, eco-friendly, molecular recognition and less-toxicity. They can self-assemble into specific lyotropic liquid crystalline phases which are stabilized by hydrogen bonds between the sugar moieties. Chirality of the sugar also affects their lyotropic and thermotropic phase behaviors [20, 39]. MEL exhibits the above-mentioned lyotropic liquid crystalline phases. The four classes of MEL with variation in their hydrophilicity show different self-assembling properties including liposomes, self-assembled monolayer, lamella phase, sponge phase, liquid lyotropic crystals and bicontinuous cubic phase [17–21, 39, 43, 70].
Formation of thermodynamically stable vesicle by MEL
![Mechanism of formation of thermodynamically stable vesicles by MEL-A/DLPC mixture [16]. L 3 MEL sponge phase; L α1 thermodynamically stable vesicle; L α Large multilamellar vesicle (○ - MEL-A negatively curved lipid; ● - DLPC zero curved lipid)](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jimb/35/12/10.1007_s10295-008-0460-4/2/m_10295_2008_460_fig7_html.gif?Expires=1747993863&Signature=Ad0I~R9nXfsbywjxBXVjF0J~4Mc3sTcTy12kOpFA3rAvp8OHqFCKZW1Hq6EBtl-XGZKYWR9xj~~kVftO51USSyUTkq4TKIUJcbGGYzfHUR7OnhJ94Rnc~QzWv4rH~GdGebGCy7gdYrRlykkB0Ir7sEcbENAjFdl3d-Vw0YTYcy1jcjNeY8MFDG1gqcSP9G3dJeNhyO5mrTh6-e~n1njmcAA-Nwwf5DKxztPlbADEqcejpxKA-3U1TDUp4Q85FbarksZxuf1Q7fhnjZSbvvoAih3BU3UAvzJQU0G9RhJ2j~O74GC4K5SvywyU3lcDJR~1bYB1dd1aYRh5hG6Brg3K-A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Mechanism of formation of thermodynamically stable vesicles by MEL-A/DLPC mixture [16]. L 3 MEL sponge phase; L α1 thermodynamically stable vesicle; L α Large multilamellar vesicle (○ - MEL-A negatively curved lipid; ● - DLPC zero curved lipid)
Multilamellar vesicles and large unilamellar vesicles
Imura et al. [19] studied the self-assembling properties of MEL-A and -B by using fluorescence-probe spectroscopy, dynamic light scattering (DLS) spectroscopy, freeze–fracture transmission electron microscopy (FF-TEM) and synchrotron small/wide-angle X-ray scattering (SAXS/WAXS) spectroscopy. They observed that the MELs self-assemble into large unilamellar vesicles (LUV) just above their critical-aggregation concentration (CAC), which was found to be 4.0 × 10−6 M and 6.0 × 10−6 M for MEL-A and MEL-B, respectively. Above a CAC (II) value of 2.0 × 10−5 M, MEL-A is found to drastically change into sponge like structure (L3) which is composed of a network of randomly connected bilayers with a water-channel diameter of 100 nm and resembles a multicomponent synthetic surfactant system. This channel dimension is relatively large when compared to those obtained with synthetic surfactants. MEL-B, which has a hydroxyl group at the C-4′ position instead of an acetyl group on mannose gives only one CAC. The self-assembled structure of MEL-B seems to gradually move from LUV to multilamellar vesicles (MLV) with lattice constant of 4.4 nm [19].
Lyotropic-liquid-crystalline phases of MEL
At high concentrations, the formation of an inverted hexagonal phase (H2) for MEL-A and a lamella phase (Lα) for MEL-B was clearly observed by using polarized optical microscopy. These results indicate that the difference in the spontaneous curvature between MEL-A and MEL-B molecules is due to an extra acetyl group present in MEL-A. This difference decides the direction of their self-assembly. The microorganisms are able to engineer distinct self-assembled structures by varying the substitutions on the polar head group [19].
Imura et al. showed on the phase diagram that MEL-A is able to self-assemble into a variety of distinctive lyotropic liquid crystals including L3, bicontinuous cubic (V2), and lamellar (Lα) phases. The lattice constants are estimated to be 11.39 and 3.58 nm for V2 and Lα, respectively. Differential scanning calorimetry (DSC) measurement revealed that the phase transition enthalpies from these Lyotropic liquid crystals (LCs) to the fluid isotropic (FI) phase are in the range of 0.22–0.44 kJ/mol. L3 region of MEL-A is spread considerably over a wide temperature range (20–65 °C) when compared to that of other surfactants [20]. This is probably due to its unique structure which is molecularly engineered by the microorganisms.
MEL-B from P. tsukubaensis (yield 20 g/L) has 1-O-β-(2′,3′-di-O-alka(e)noyl-6′-O-acetyl-d-mannopyranosyl)-d-erythritol (Fig. 6) [12], which is a diastereomer of the conventional MEL-B. This new diastereomer self-assembles into a lamellar (Lα) phase over a remarkably wide range of concentrations and temperatures whereas MEL-A (diacetyl) forms L3, V2, and Lα phases. It is observed that the difference in the number of acetyl groups and the configuration of erythritol moiety play an important role in the aqueous-phase behavior of MEL/water mixture. The interplanar distance (d) of Lα phase of MEL-B is estimated to be 4.7 nm at low concentrations (≤60 wt%) and this d-spacing decreases with increase in concentration (~3.1 nm at >60%). This phase is found to be stable up to 95 °C and below a concentration of 85% (wt). The melting temperature of the liquid crystalline phase dramatically decreases with increase in MEL-B concentration (above 85 wt%). The MEL-B is able to form vesicle of dimension 1–5 μm [70]. MEL-C from P. Siamensis CBS 9960 forms liquid crystal phases such as hexagonal (H) and Lα phases at a wide range of concentrations [51].
Coacervate formation of natural glycolipids
Coacervate is a spherical aggregation of lipid molecules making up a colloidal inclusion, which is held together by hydrophobic forces. Coacervate formation by MEL-A and vesicle formation by MEL-B have been observed and as mentioned before this difference arises due to the presence of 4′-O-acetyl group in MEL-B [17].
Self-assembled monolayer structures of MEL
![Schematic representation of a hybrid bilayer membrane and molecular interaction [19]](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jimb/35/12/10.1007_s10295-008-0460-4/2/m_10295_2008_460_fig8_html.gif?Expires=1747993863&Signature=ZPBLYHBRkbsGbXrSx3POS3ICKa4q8ckMjLNChd1FN5ZLz9Z5hec2Cy444FJCkI4rfFOkWvgSIxAGMTr0FKhwwuQq0W1YR2awjCGVKzm7fkqV4OF6krkg-KFci1oKvomt6vdPmrua88J4uP9UcgVRrVE8Fp0~ilu5B3jRdVamVYc8WRiqf02gLcKAz8rVpMkKdWJJoJd3nTlWN5fxVDx04TRvU6GoA2uTXsQzKjPvPCM193RdJwLn0VL-9vweOzl3aLwYSgURqC~V7xbVKTzzH7vNaExptOIqH-HJrUThMJo5dLdKIKMQEMp1c18H10uDF~bLRdY8KlYgjXA1diS1bA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Schematic representation of a hybrid bilayer membrane and molecular interaction [19]
Homologs of MEL and their self-assembling properties
Type of MEL . | Size of the vesicles (μm) . | Critical aggregation concentration (M) . | Self-assembling structures . | Referenes . |
---|---|---|---|---|
MEL-A | 1–20 | 4.0 × 10−6 | Spherical droplet, Large unilamellar vesicles (LUV) sponge (L3), bicontinuous cubic (V2) and lamella | [17–20, 39] |
Conventional MEL-B | 1–20 | 6.0 × 10−6 | Giant vesicles, multi lamellar vesicles (MLV) | [17, 19, 39] |
MEL-B (new diastereomer P. tsukubaensis) | 1–5 | NA | Lamellar (Lα) phase over a wide concentration and temperature ranges, vesicle | [67] |
MEL-C | NA | NA | Myelines and lamella (Lα) | [46] |
MEL-C from P. siamensis CBS 9960 | NA | NA | Hexagonal (H) and lamella (Lα) | [57] |
Type of MEL . | Size of the vesicles (μm) . | Critical aggregation concentration (M) . | Self-assembling structures . | Referenes . |
---|---|---|---|---|
MEL-A | 1–20 | 4.0 × 10−6 | Spherical droplet, Large unilamellar vesicles (LUV) sponge (L3), bicontinuous cubic (V2) and lamella | [17–20, 39] |
Conventional MEL-B | 1–20 | 6.0 × 10−6 | Giant vesicles, multi lamellar vesicles (MLV) | [17, 19, 39] |
MEL-B (new diastereomer P. tsukubaensis) | 1–5 | NA | Lamellar (Lα) phase over a wide concentration and temperature ranges, vesicle | [67] |
MEL-C | NA | NA | Myelines and lamella (Lα) | [46] |
MEL-C from P. siamensis CBS 9960 | NA | NA | Hexagonal (H) and lamella (Lα) | [57] |
NA not available
Homologs of MEL and their self-assembling properties
Type of MEL . | Size of the vesicles (μm) . | Critical aggregation concentration (M) . | Self-assembling structures . | Referenes . |
---|---|---|---|---|
MEL-A | 1–20 | 4.0 × 10−6 | Spherical droplet, Large unilamellar vesicles (LUV) sponge (L3), bicontinuous cubic (V2) and lamella | [17–20, 39] |
Conventional MEL-B | 1–20 | 6.0 × 10−6 | Giant vesicles, multi lamellar vesicles (MLV) | [17, 19, 39] |
MEL-B (new diastereomer P. tsukubaensis) | 1–5 | NA | Lamellar (Lα) phase over a wide concentration and temperature ranges, vesicle | [67] |
MEL-C | NA | NA | Myelines and lamella (Lα) | [46] |
MEL-C from P. siamensis CBS 9960 | NA | NA | Hexagonal (H) and lamella (Lα) | [57] |
Type of MEL . | Size of the vesicles (μm) . | Critical aggregation concentration (M) . | Self-assembling structures . | Referenes . |
---|---|---|---|---|
MEL-A | 1–20 | 4.0 × 10−6 | Spherical droplet, Large unilamellar vesicles (LUV) sponge (L3), bicontinuous cubic (V2) and lamella | [17–20, 39] |
Conventional MEL-B | 1–20 | 6.0 × 10−6 | Giant vesicles, multi lamellar vesicles (MLV) | [17, 19, 39] |
MEL-B (new diastereomer P. tsukubaensis) | 1–5 | NA | Lamellar (Lα) phase over a wide concentration and temperature ranges, vesicle | [67] |
MEL-C | NA | NA | Myelines and lamella (Lα) | [46] |
MEL-C from P. siamensis CBS 9960 | NA | NA | Hexagonal (H) and lamella (Lα) | [57] |
NA not available
Applications
MELs are considered as molecules of multifunctionality due to their exceptional surface activity; high yield (above 100 g/L); biocompatibility; self-assembling properties; antimicrobial activities; and biochemical functions [13, 59].
Antimicrobial activity of MEL
Both MEL-A and MEL-B show strong activity against gram positive bacteria, weak activity against gram negative bacteria and no activity against fungi. The minimum inhibitory concentrations against gram-positive bacteria are significantly lower than those of sucrose and sorbitan monoesters of fatty acids. Other MELs accumulated in the cell of Schizonella melanogramma also exhibit antibacterial and antifungal activities [5]. Matsumura et al. reported that mannopyranosyl groups are the most effective amongst the n-alkyl glycosides tested against microorganisms. It may not be difficult to enhance the antimicrobial activity of the present MELs further by the chemical modification of the sugar moiety [37].
MEL induces cell differentiation and apoptosis
MEL-A and -B have excellent growth inhibition and differentiation-inducing activities against human leukemia cells including myelogenous leukemia cell K562 [26], promyelocytic leukemia cell HL60 [25, 26] and the human basophilic leukemia cell line KU812 [25, 42]. Both inhibit the growth of HL60 cells at concentrations between 5 and 10 μM and also induce changes to their morphology. They (at 10 mg/L) also induce granulocytic differentiation [27, 42] and inhibit the activity of phospholipid- and Ca2+-dependent protein kinase C in HL 60 cells. MEL-A inhibits the serine/threonine phosphorylation of a 30 kDa protein in HL-60 cells and the tyrosine phosphorylation of 55-, 65-, 95-, 135-kDa proteins in K562 cells [42]. Therefore, MEL appears to directly affect intracellular signal transduction through phosphate cascade systems. Both induce significantly the neurite outgrowth of rat pheochromocytoma PC-12 cells and partial cellular differentiation [42, 68]. MEL-A has been recently demonstrated to inhibit the growth of mouse melanoma B 16 cells in a dose-dependent manner. At 10 μM concentration it causes the condensation of chromatin, fragmentation of DNA, and arrest of sub-G1, which indicates that the cells are undergoing apoptosis. MEL is also found to induce tyrosinase activity and enhances the production of melanin [71]. This trigger of mouse melanoma B 16 cells may be through a signaling pathway that involves protein kinase Cα (PKCα) [73].
Purification of glycoprotein
MEL-A, -B and -C exhibit high binding affinity to human immunoglobulins [15, 16, 39, 43]. They also show binding affinity towards Ig M and other glycoproteins. Self-assembled monolayer of MEL-A show six times higher affinity than the immobilized MEL-A in PHEMA [21]. All these results show their potential application as a ligand for the purification of lectins.
Vehicles for gene delivery
MELs can be used as a vehicle for gene and drug delivery due to their ability to form thermodynamically stable vesicles with the ability to fuse with the membrane [23, 24, 43, 65, 66]. Among various biosurfactants, MEL-A provides the highest sufficiency [24]. It remarkably accelerates the adhesion of positively charged liposome–DNA complex to the cell membrane and incorporates this complex into the cell [23, 43].
Inhibit ice agglomeration
Ice slurry systems are finding wide applications as environmental friendly cold thermal storage units, especially as air conditioners [22, 42]. In these units, there is a possibility for the ice particles to agglomerate or grow together and block the pipeline, causing superfluous power loads thereby leading to loss of efficiency. MEL at low concentration (10 mg/L) gets adsorbed on the ice surface and suppresses the agglomeration of ice particles. Their effective performance has also been tested successfully in a large scale model (300 L) [22, 41, 42].
Future perspectives
The past 60 years of research on MEL has proved that it is the most promising microbial extracellular glycolipid ever known because of its high yield, excellent surface activity, diverse biochemical functions, biocompatibility and its wide range of applications. However, the commercial viability of MEL depends upon its production cost which has to be significantly lowered with the help of recent developments in bioprocess technology together with the advanced separation techniques. Hence the following research topics need to be explored:
Reduce the production cost by using cheaper raw material, optimize the production conditions together with downstream processes.
Engineer the overproducing mutant and recombinant strains.
Develop structure-activity relationship to tailor the compounds with the required features. This can be done by making derivatives (by chemical or enzymatic synthesis and modifications) and analyzing their corresponding performance.
Study on the various factors that determine the self-assembling properties to enhance their scope of applications in the biomedical field.
Identify the enzymes involved in their biosynthesis and regulate or augment the production of only one type of MEL with higher yield.
Determine the role of cell wall components (of Candida sp. Torulopsis sp. and Pseudozyma sp.) and understand how they tolerate high levels of MEL. This may provide new approaches to increase the yield as well as this knowledge could be extrapolated for other classes of BSs.
Since MEL can interact with glycoproteins (lectins), use them as model systems to study the mechanism of different biochemical functions.
Application of MEL as a vehicle for drug and gene delivery.
Establish mechanisms of antimicrobial and antitumor activities of MEL.
Similarity studies on the enzymes involved in the synthesis of different classes of glycolipid (rhamnolipids, sophorolipids, cellobiose lipids, MEL, etc.) may give insight into the active site specificity of enzymes for the synthesis of particular kind of glycolipid.
Understand the role of MEL production in microbial physiology.
Conclusion
Mannosylerythritol lipid, 2,3-di-O-alka(e)noyl-β- d-mannopyranosyl-(1 → 4)-O-meso-erythritol, partially acetylated at C4 and/or C6 position, is produced by Ustilago sp., Schizonella sp., and Pseudozyma sp. The type of MEL produced varies with the strains and the species of Pseudozyma. Hence its production can be used as an important taxonomic index to identify Pseudozyma yeast. This is considered as a most promising biosurfactant because of its high yield, excellent surface activity, diverse biochemical functions and biocompatibility. MELs exhibit interesting self-assembling properties which enhance their efficiency in gene transfection. Recent research on the ability of MEL-A to form water-in-oil microemulsion without the use of a cosurfactant seems to add an impetus to the development of the microemulsion technology which is limited due to the fact that they require cosurfactants, salts or alcohols for stabilization. MEL induces differentiation of several carcinoma cell lines. They exhibit antimicrobial and antitumor activities. The high binding affinity of the monolayer of MEL-A to the immunoglobulins helps in the purification of lectins. However their large scale production and recovery processes have to be optimized in order to compete economically with the chemical surfactants. Even though enormous information is available on the growing number of microorganisms that produce MEL with unique physico-chemical properties, very less knowledge is available on the enzymes involved in each step of its synthesis. Its regulation, structure–function relationship, mechanism of its biochemical functions like differentiation on carcinoma cell lines are poorly understood and needs major research thrust.
References
Im JH, Nakane T, Yanagishita H, Ikegami T, Kitamoto D (2001) Mannosylerythritol lipid, a yeast extracellular glycolipid, shows high binding affinity towards human immunoglobulin G. BMC Biotechnol 1:5. http://www.biomedcentral.com/1472-6750/1/5. doi:10.1186/1472-6750-1-5
Tanaka A, Fukui S (1989) Metabolism of n-alkane. In: The yeast, vol 3, 2nd edn. Academic Press, London, p 261–287
Vertesy L, Kurz M, Wink J, Noelken G (2002) Ustilipides, method for the production and the use thereof. US Patent 6,472,158
Worakitkanchanakula W, Imurab T, Fukuokab T, Moritab T, Sakaia H, Abea M et al. (2008) Aqueous-phase behavior and vesicle formation of natural glycolipid biosurfactant, mannosylerythritol lipid-B. Colloids Surf B Biointerfaces. doi:10.1016/j.colsurfb.2008.03.009